These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12546649)

  • 1. Agonist binding to peptide hormone receptors.
    Wheatley M; Hawtin SR; Wesley VJ; Howard HC; Simms J; Miles A; McEwan K; Parslow RA
    Biochem Soc Trans; 2003 Feb; 31(Pt 1):35-9. PubMed ID: 12546649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of a subdomain of the N-terminus of the V1a vasopressin receptor for binding agonists but not antagonists; functional rescue by the oxytocin receptor N-terminus.
    Hawtin SR; Wesley VJ; Parslow RA; Patel S; Wheatley M
    Biochemistry; 2000 Nov; 39(44):13524-33. PubMed ID: 11063589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist-specific, high-affinity binding epitopes are contributed by an arginine in the N-terminus of the human oxytocin receptor.
    Wesley VJ; Hawtin SR; Howard HC; Wheatley M
    Biochemistry; 2002 Apr; 41(16):5086-92. PubMed ID: 11955056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an extracellular segment of the oxytocin receptor providing agonist-specific binding epitopes.
    Hawtin SR; Howard HC; Wheatley M
    Biochem J; 2001 Mar; 354(Pt 2):465-72. PubMed ID: 11171127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single residue (arg46) located within the N-terminus of the V1a vasopressin receptor is critical for binding vasopressin but not peptide or nonpeptide antagonists.
    Hawtin SR; Wesley VJ; Parslow RA; Simms J; Miles A; McEwan K; Wheatley M
    Mol Endocrinol; 2002 Mar; 16(3):600-9. PubMed ID: 11875119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-terminal juxtamembrane segment of the V1a vasopressin receptor provides two independent epitopes required for high-affinity agonist binding and signaling.
    Hawtin SR; Wesley VJ; Simms J; Argent CC; Latif K; Wheatley M
    Mol Endocrinol; 2005 Nov; 19(11):2871-81. PubMed ID: 15994199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular loops and ligand binding to a subfamily of Family A G-protein-coupled receptors.
    Wheatley M; Simms J; Hawtin SR; Wesley VJ; Wootten D; Conner M; Lawson Z; Conner AC; Baker A; Cashmore Y; Kendrick R; Parslow RA
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):717-20. PubMed ID: 17635132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling.
    Postina R; Kojro E; Fahrenholz F
    Adv Exp Med Biol; 1998; 449():371-85. PubMed ID: 10026828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
    J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic analysis of the entire second extracellular loop of the V(1a) vasopressin receptor: key residues, conserved throughout a G-protein-coupled receptor family, identified.
    Conner M; Hawtin SR; Simms J; Wootten D; Lawson Z; Conner AC; Parslow RA; Wheatley M
    J Biol Chem; 2007 Jun; 282(24):17405-12. PubMed ID: 17403667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An arginyl in the N-terminus of the V1a vasopressin receptor is part of the conformational switch controlling activation by agonist.
    Hawtin SR; Wesley VJ; Simms J; Parslow RA; Miles A; McEwan K; Keen M; Wheatley M
    Eur J Biochem; 2003 Dec; 270(23):4681-8. PubMed ID: 14622255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nonpeptide oxytocin receptor agonist WAY 267,464: receptor-binding profile, prosocial effects and distribution of c-Fos expression in adolescent rats.
    Hicks C; Jorgensen W; Brown C; Fardell J; Koehbach J; Gruber CW; Kassiou M; Hunt GE; McGregor IS
    J Neuroendocrinol; 2012 Jul; 24(7):1012-29. PubMed ID: 22420322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking ligands to vasopressin and oxytocin receptors via genetic algorithm.
    Politowska E; Drabik P; Kazmierkiewicz R; Ciarkowsk J
    J Recept Signal Transduct Res; 2002; 22(1-4):393-409. PubMed ID: 12503629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysine 270 in the third intracellular domain of the oxytocin receptor is an important determinant for G alpha(q) coupling specificity.
    Yang M; Wang W; Zhong M; Philippi A; Lichtarge O; Sanborn BM
    Mol Endocrinol; 2002 Apr; 16(4):814-23. PubMed ID: 11923477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family.
    Chini B; Mouillac B; Ala Y; Balestre MN; Cotte N; Trumpp-Kallmeyer S; Hoflack J; Elands J; Hibert M; Manning M
    Adv Exp Med Biol; 1995; 395():321-8. PubMed ID: 8713982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist-specific requirement for a glutamate in transmembrane helix 1 of the oxytocin receptor.
    Wootten DL; Simms J; Massoura AJ; Trim JE; Wheatley M
    Mol Cell Endocrinol; 2011 Feb; 333(1):20-7. PubMed ID: 21130837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of agonist binding sites of vasopressin and oxytocin receptors.
    Mouillac B; Chini B; Balestre MN; Jard S; Barberis C; Manning M; Tribollet E; Trumpp-Kallmeyer S; Hoflack J; Elands J
    Adv Exp Med Biol; 1995; 395():301-10. PubMed ID: 8713980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological lineage analysis revealed the binding affinity of broad-spectrum substance P antagonists to receptors for gonadotropin-releasing peptide.
    Arai K; Kashiwazaki A; Fujiwara Y; Tsuchiya H; Sakai N; Shibata K; Koshimizu TA
    Eur J Pharmacol; 2015 Feb; 749():98-106. PubMed ID: 25592317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.
    Guillon G; Pena A; Murat B; Derick S; Trueba M; Ventura MA; Szeto HH; Wo N; Stoev S; Cheng LL; Manning M
    J Pept Sci; 2006 Mar; 12(3):190-8. PubMed ID: 16130178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
    Haskell-Luevano C; Cone RD; Monck EK; Wan YP
    Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.